Ledger.Open graph →
SEC Form D · filed April 5, 2023

PharmaCann Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Other
Location
CHICAGO, IL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Brett Novey · Chicago, ILExec · DirectorDavid P. Chiovetti · Chicago, ILExecPatrick P. Unzicker · Chicago, ILExecLori P. Richards · Chicago, ILDirectorJames P. Barry · Chicago, ILDirectorJohn P. Lord · Chicago, ILDirectorStephen P. Schuler · Chicago, ILDirectorDaniel P. Roth · Chicago, ILExecRobert P. Mcqueen · Chicago, ILExecJohn P. Mccarthy · Chicago, ILDirectorMark Mccurdy, M.D · Fort Worth, TXDirectorJeff Spain · Rialto, CAExecAndrew T. Messer · Jacksonville, FLExec · DirectorRafael La Porta De Castro · Rialto, CADirectorJeffrey N. Pentland · TORONTO, Ontario, CanadaExecJustin J. Dennis · Jacksonville, FLDirectorKatherine N. Gurney · TORONTO, Ontario, CanadaExecJeff N. Lucassen · TORONTO, Ontario, CanadaDirectorAjith Pai · Fort Worth, TXExecIan Balina · Beaverton, ORDirectorBruce R. Jenkyn-Jones · London, United KingdomDirectorEdward Shehwen · Mt. Laurel, NJExec · DirectorParent of the General Partner Richard Impax Asset Management Group PLC · London, United KingdomDirectorKen Johnson · Mt. Laurel, NJExecBernd B. Gottschalk · Pleasanton, CAExecNicholas Edwards · Fargo, NDExecJonathon B. Husby · Pleasanton, CADirectorJeff Mcdermott · Fargo, NDDirectorMatthew Fisch · Pleasanton, CADirectorConor B. Tierney · Pleasanton, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗